LT - Deriniai, apimantys 6-benzilfenil-2-sieros tetrahidropiran-3,4,5-triolio darinius, kaip natrio-gliukozės bendrų transporterių 1 ir 2 inhibitoriai, skirti naudoti diabetinių pacientų gydymui
EN - COMBINATIONS COMPRISING 6-BENZYLPHENYL-2- SULFURTERAHYDROPYRAN-3,4,5-TRIOL DERIVATIVES AS INHIBITORS OF SODIUM -GLUCOSE COTRANSPORTERS 1 AND 2 FOR USE IN DIABETIC PATIENTS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/351 |
(2006.01) |
|
|
A61P 9/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2542236 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
11707324.7 |
|
Date of filing the European patent application |
2011-03-01 |
| (97) |
Date of publication of the European application |
2013-01-09 |
| (45) |
Date of publication and mention of the grant of the patent |
2016-10-26
|
| (46) |
Date of publication of the claims translation |
2017-03-27
|
PCT application
| (86) |
Number |
PCT/US2011/026591 |
|
Date |
2011-03-01 |
PCT application publication
| (87) |
Number |
WO 2011/109333 |
|
Date |
2011-09-09 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
309592 P |
2010-03-02
|
US |
Inventors
| (72) |
BROWN, Philip Manton, US
FREIMAN, Joel Philip, US
POWELL, David Reed, US
|
Grantee
| (73) |
Lexicon Pharmaceuticals, Inc.,
8800 Technology Forest Place, The Woodlands, TX 77381,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Deriniai, apimantys 6-benzilfenil-2-sieros tetrahidropiran-3,4,5-triolio darinius, kaip natrio-gliukozės bendrų transporterių 1 ir 2 inhibitoriai, skirti naudoti diabetinių pacientų gydymui |
| |
COMBINATIONS COMPRISING 6-BENZYLPHENYL-2- SULFURTERAHYDROPYRAN-3,4,5-TRIOL DERIVATIVES AS INHIBITORS OF SODIUM -GLUCOSE COTRANSPORTERS 1 AND 2 FOR USE IN DIABETIC PATIENTS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2026-02-13 |
16 |
347.00
EUR
|
Next renewal fee
|
2027-03-01 |
